Inhibitors | Comment | Organism | Structure |
---|---|---|---|
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid | - |
Sus scrofa |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Sus scrofa | - |
- |
- |
Purification (Comment) | Organism |
---|---|
partial | Sus scrofa |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
artery | vascular | Sus scrofa | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
assay methods | Sus scrofa |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
prostaglandin G2 | - |
Sus scrofa | prostaglandin I2 + 15-hydroperoxyprostacyclin | 15-hydroperoxyprostacyclin decomposes to 6,15-diketo-prostaglandin F1alpha | ? | |
Prostaglandin H2 | - |
Sus scrofa | Prostaglandin I2 | prostaglandin I2 | ? |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
6.8 | 7.5 | - |
Sus scrofa |